儿童穿透性角膜移植治疗先天性角膜混浊的临床效果
回顾性系列病例研究纳入2009年6月至2016年12月爱尔眼科医院集团12例(16只眼)3岁以下先天性角膜混浊患儿行穿透性角膜移植术,随访33.17±22.60个月,所有手术成功且无术中并发症,除1例3岁角膜皮样瘤患儿外其余患眼术后1周至1个月视力明显提高,4例(4只眼)发生排斥反应。
要点
- 3岁以下先天性角膜混浊患儿行穿透性角膜移植术后多数视力明显提高。
- 随访期内4例(4只眼)发生排斥反应,其中3例为Peter异常患儿。
- 术后密切随访、及时处理并发症及规范视功能训练是成功关键。
核心结论
- 婴幼儿先天性角膜混浊可以通过穿透性角膜移植获得有效治疗,术后密切随访、及时处理并发症、家长积极配合给予规范视功能训练,均能获得比较好的视力。
研究设计与样本
- 回顾性系列病例研究,纳入2009年6月至2016年12月于爱尔眼科医院集团行穿透性角膜移植术的3岁以下先天性角膜混浊患儿12例(16只眼),男性6例(9只眼),女性6例(7只眼),年龄平均为(16.04±12.48)个月。
主要发现
- 术后随访(33.17±22.60)个月,除1例单眼皮样瘤全层混浊患儿因3岁时手术、术后经过半年视力部分提高外,其余患者术后均在1周至1个月时间内视力获得明显提高。
- 所有患儿手术均获得成功,术中无并发症发生。
- 随访期内4例(4只眼)发生排斥反应,其中3例Peter异常患儿发生急性排斥反应,药物控制后1例33个月的患儿植片保持半透明但视力较前明显提高,2例1岁以下患儿植片恢复完全透明。
- 1例3岁Peter异常患儿视力明显提高,术后2年发生免疫排斥反应致植片混浊,再次PKP术后半年又发生免疫排斥反应导致植片混浊,该患儿另一只眼术后早期继发青光眼,抗青光眼手术失败后植片混浊。
- 1例(2只眼)巩膜化角膜患儿术后1年时缝线松动未能及时发现,导致植片溃疡感染穿孔。
关键数值与推荐
- 术前所有患眼均有光照反应,其中4例(6只眼)有追光反应。
- 所有患儿均为先天性角膜混浊,其中Peter异常Ⅰ型8例(11只眼),巩膜化角膜2例(3只眼),中央部角膜皮样瘤合并虹膜粘连者2例(2只眼)。
- 手术时年龄<1岁的7例(7只眼)。
- 除1例(2只眼)行PKP联合白内障摘除术外,其余均行单纯PKP术。
临床怎么用
- 术后严密复查角膜植片、缝线、前房情况,并检查眼压及视力。
- 术后密切随访、及时处理并发症、家长积极配合给予规范视功能训练。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To report the clinical results of pediatric penetrating keratoplasty (PKP) in patients under 3 years old with congenital corneal opacity. Methods: Retrospective study. Sixteen eyes of 12 patients who were treated with PKP in Aier Eye Hospital Group from June 2009 to December 2016 were enrolled in this study. All the patients were diagnosed as congenital corneal opacities: 8 cases (11 eyes) with Peter's anomaly I, 2 cases (3 eyes) with sclerocornea, and 2 cases (2 eyes) with corneal dermoid tumor combined with iris synechia. Seven cases (7 eyes) were under 1 year old. Eight cases (10 eyes) could not follow the light. Only 1 case (2 eyes) received PKP with extracapsular cataract extraction, and the others only had PKP. Postoperative examinations were performed more frequently than in adults, and sometimes general anesthesia was needed. Results: The follow-up period was from 8 months to 6 years (33.17±22.60 months). The postoperative visual acuity improvement was found in all eyes from 1 week to 1 month after surgery except a 3-year-old patient with corneal dermoid tumor with serious esotropia. All the surgeries were successful without intraoperative complications. Graft rejection occurred in 4 cases (4 eyes). The graft of a 33-month-old patient became semitransparent. The grafts of 2 cases under 1 year old were clear after drug therapy. And the vision of a 3-year-old patient with Peter anomaly improved obviously, but immune rejection occurred 2 years after surgery. The second PKP was performed, but rejection occurred again. Secondary glaucoma was found in the other eye early after operation; anti-glaucoma surgery failed, and the graft became cloudy. Graft infection associated with loosened sutures was observed in one case (2 eyes) of sclerocornea, and the second PKP failed. Conclusions: For the patients with congenital corneal opacities, there is often a noticeable visual improvement after PKP. Good postoperative care, appropriate amblyopia treatment and timely examination are the keys to success. (Chin J Ophthalmol, 2017, 53: 941-946). 目的: 探讨3岁以下婴幼儿先天性角膜混浊行穿透性角膜移植的临床疗效。 方法: 回顾性系列病例研究。收集2009年6月至2016年12月于爱尔眼科医院集团行穿透性角膜移植术(PKP)的患儿12例(16只眼),其中男性6例(9只眼),女性6例(7只眼),年龄平均为(16.04±12.48)个月。所有患儿均为先天性角膜混浊,其中Peter异常Ⅰ型8例患者(11只眼);巩膜化角膜2例患者(3只眼);中央部角膜皮样瘤合并虹膜粘连者2例(2只眼)。手术时年龄<1岁的7例(7只眼)。术前观察患眼均有光照反应,其中4例(6只眼)有追光反应。除1例(2只眼)行PKP联合白内障摘除术外,其余均行单纯PKP术。术后严密复查角膜植片、缝线、前房情况,并检查眼压及视力。 结果: 术后随访(33.17±22.60)个月,除1例单眼皮样瘤全层混浊患儿因3岁时手术,术后经过半年视力部分提高外,其余患者术后均在1周至1个月时间内视力获得明显提高。所有患儿手术均获得成功,术中无并发症发生。随访期内,4例(4只眼)发生排斥反应,其中3例Peter异常患儿发生急性排斥反应,药物控制后1例33个月的患儿植片保持半透明,但视力较前明显提高;2例1岁以下患儿植片恢复完全透明;1例3岁Peter异常患儿视力明显提高,术后2年发生免疫排斥反应,植片混浊,再次PKP术后半年又发生免疫排斥反应,导致植片混浊;该患儿另一只眼术后早期继发青光眼,抗青光眼手术失败,植片混浊。1例(2只眼)巩膜化角膜患儿术后1年时缝线松动未能及时发现,导致植片溃疡感染穿孔。 结论: 婴幼儿先天性角膜混浊可以通过PKP获得有效的治疗,术后密切随访,及时处理并发症,家长积极配合给予规范视功能训练,均能获得比较好的视力。(中华眼科杂志,2017,53:941-946).
引用
- Li SW, Liu C, Chen TH, et al. [Clinical effects of pediatric penetrating keratoplasty for congenital corneal opacity]. Zhonghua Yan Ke Za Zhi. 2017. PMID: 29325387. doi:10.3760/cma.j.issn.0412-4081.2017.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。